Advertisement

Current Infectious Disease Reports

, Volume 13, Issue 4, pp 308–316 | Cite as

Pericarditis: Pathophysiology, Diagnosis, and Management

  • Massimo Imazio
Article

Abstract

Pericarditis, the most common disease of the pericardium, may be isolated or a manifestation of a systemic disease. The etiology of pericarditis is varied and includes infectious (especially viral and tuberculosis) and noninfectious causes (autoimmune and autoinflammatory diseases, pericardial injury syndromes, and cancer [especially lung cancer, breast cancer, and lymphomas]). Most cases remain idiopathic with a conventional diagnostic evaluation. A targeted etiologic search should be directed to the most common cause on the basis of the patient’s clinical background, epidemiologic issues, specific presentations, and high-risk features associated with specific etiologies or complications (fever higher than 38°C, subacute onset, large pericardial effusion, cardiac tamponade, lack of response to NSAIDs). The management of pericardial diseases is largely empiric because of the relative lack of randomized trials. NSAIDs are the mainstay of empiric anti-inflammatory therapy, with the possible addition of colchicine to prevent recurrences.

Keywords

Pericarditis Pathophysiology Diagnosis Therapy Management 

Notes

Disclosure

No potential conflict of interest relevant to this article was reported.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    • Imazio M, Cecchi E, Demichelis B, et al. Myopericarditis versus viral or idiopathic acute pericarditis. Heart. 2008;94:498–501. This was a contemporary prospective study with a comparison of clinical features and prognosis of simple acute pericarditis and myopericarditis.PubMedCrossRefGoogle Scholar
  2. 2.
    • Imazio M, Brucato A, Trinchero R, Adler Y. Diagnosis and management of pericardial diseases. Nat Rev Cardiol. 2009;6:743–51. This is an updated review on the diagnosis and management of pericardial diseases.PubMedCrossRefGoogle Scholar
  3. 3.
    •• Imazio M, Spodick DH, Brucato A, et al. Controversial issues in the management of pericardial diseases. Circulation. 2010;121:916–28. This is a contemporary review of the main controversies surrounding the management of pericardial diseases.PubMedCrossRefGoogle Scholar
  4. 4.
    • Imazio M, Brucato A, Derosa FG, et al. Aetiological diagnosis in acute and recurrent pericarditis: when and how. J Cardiovasc Med (Hagerstown). 2009;10:217–30. This is a comprehensive review on the etiology and diagnosis of pericarditis.CrossRefGoogle Scholar
  5. 5.
    Imazio M, Mayosi BM, Brucato A, et al. Triage and management of pericardial effusion. J Cardiovasc Med (Hagerstown). 2010;11:928–35.CrossRefGoogle Scholar
  6. 6.
    Castagna L, Furst S, El Cheikh J, et al. Parvovirus B19 as an etiological agent of acute pleuro-pericarditis. Bone Marrow Transplant. 2010 Apr 26. (Epub ahead of print).Google Scholar
  7. 7.
    Imazio M, Spodick DH, Brucato A, et al. Diagnostic issues in the clinical management of pericarditis. Int J Clin Pract. 2010;64:1384–92.PubMedCrossRefGoogle Scholar
  8. 8.
    Ntsekhe M, Mayosi BM. Cardiac manifestations of HIV infection: an African perspective. Nat Clin Pract Cardiovasc Med. 2009;6:120–7.PubMedCrossRefGoogle Scholar
  9. 9.
    Mookadam F, Moustafa SE, Sun Y, et al. Infectious pericarditis: an experience spanning a decade. Acta Cardiol. 2009;64:297–302.PubMedCrossRefGoogle Scholar
  10. 10.
    Inkster T, Khanna N, Diggle M, Sonecki P. Diagnosis of pneumococcal pericarditis using antigen testing and polymerase chain reaction. Scand J Infect Dis. 2010;42:791–3.PubMedCrossRefGoogle Scholar
  11. 11.
    Levy PY, Gouriet F, Habib G, et al. Diagnosis of Coxiella burnetii pericarditis by using a systematic prescription kit in cases of pericardial effusion: an 8-year experience. Clin Microbiol Infect. 2009;15 Suppl 2:173–5.PubMedCrossRefGoogle Scholar
  12. 12.
    Abu-Hijleh M, Evans S, Aswad B. Pleuropericarditis in a patient with inflammatory bowel disease: a case presentation and review of the literature. Lung. 2010;188:505–10.PubMedCrossRefGoogle Scholar
  13. 13.
    Cantarini L, Lucherini OM, Cimaz R, et al. Idiopathic recurrent pericarditis refractory to colchicine treatment can reveal tumor necrosis factor receptor-associated periodic syndrome. Int J Immunopathol Pharmacol. 2009;22:1051–8.PubMedGoogle Scholar
  14. 14.
    Okutur K, Seber S, Oztekin E, et al. Recurrent pericarditis as the initial manifestation of Familial Mediterranean fever. Med Sci Monit. 2008;14:CS139–41.PubMedGoogle Scholar
  15. 15.
    Cantarini L, Lucherini OM, Baldari CT, et al. Familial clustering of recurrent pericarditis may disclose tumour necrosis factor receptor-associated periodic syndrome. Clin Exp Rheumatol. 2010;28:405–7.PubMedGoogle Scholar
  16. 16.
    Erlich JF, Paz Z. Postpericardial injury syndrome: an autoimmune phenomenon. Clin Rev Allergy Immunol. 2010;38:156–8.PubMedCrossRefGoogle Scholar
  17. 17.
    Imazio M, Negro A, Belli R, et al. Frequency and prognostic significance of pericarditis following acute myocardial infarction treated by primary percutaneous coronary intervention. Am J Cardiol. 2009;103:1525–9.PubMedCrossRefGoogle Scholar
  18. 18.
    • Imazio M, Trinchero R, Brucato A, et al. COPPS Investigators. COlchicine for the Prevention of the Post-pericardiotomy Syndrome (COPPS): a multicentre, randomized, double-blind, placebo-controlled trial. Eur Heart J. 2010;31:2749–54. This is the largest double-blind, randomized trial supporting the efficacy and safety of colchicine for the primary prevention of the PPS.PubMedCrossRefGoogle Scholar
  19. 19.
    Hamza A, Tunick PA, Kronzon I. Echocardiographic manifestations of complications of radiation therapy. Echocardiography. 2009;26:724–8.PubMedCrossRefGoogle Scholar
  20. 20.
    •• Brucato A, Maestroni S, Cumetti D, et al. Recurrent pericarditis: infectious or autoimmune? Autoimmun Rev. 2008;8:44–7. This is a contemporary updated review on the pathogenesis of recurrent pericarditis.PubMedCrossRefGoogle Scholar
  21. 21.
    Imazio M, Brucato A, Doria A, et al. Antinuclear antibodies in recurrent idiopathic pericarditis: prevalence and clinical significance. Int J Cardiol. 2009;136:289–93.PubMedCrossRefGoogle Scholar
  22. 22.
    • Caforio AL, Brucato A, Doria A, et al. Anti-heart and anti-intercalated disk autoantibodies: evidence for autoimmunity in idiopathic recurrent acute pericarditis. Heart. 2010;96:779–84. This was a contemporary prospective study investigating the pathogenesis of IRAP.PubMedCrossRefGoogle Scholar
  23. 23.
    • Cantarini L, Imazio M, Brizi MG, et al. Role of autoimmunity and autoinflammation in the pathogenesis of idiopathic recurrent pericarditis. Clin Rev Allergy Immunol. 2010;(Epub ahead of print). This is an updated review on the role of autoimmunity and autoinflammatory conditions in the pathogenesis of recurrent pericarditis.Google Scholar
  24. 24.
    •• Khandaker MH, Espinosa RE, Nishimura RA, et al. Pericardial disease: diagnosis and management. Mayo Clin Proc. 2010;85(6):572–93. This is an article on the Mayo Clinic experience and a review of the diagnosis and management of pericardial diseases.PubMedCrossRefGoogle Scholar
  25. 25.
    • Imazio M, Brucato A, Maestroni S, et al. Prevalence of C-reactive protein elevation and time course of normalization in acute pericarditis: implications for the diagnosis, therapy, and prognosis of pericarditis. Circulation. 2011 Mar 15;123(10):1092–7 (Epub 2011 Feb 28). This was the first prospective cohort study on time course of C-reactive protein normalization in acute pericarditis and its therapeutic implications.Google Scholar
  26. 26.
    Punja M, Mark DG, McCoy JV, et al. Electrocardiographic manifestations of cardiac infectious-inflammatory disorders. Am J Emerg Med. 2010;28:364–77.PubMedCrossRefGoogle Scholar
  27. 27.
    Calabrese F, Carturan E, Thiene G. Cardiac infections: focus on molecular diagnosis. Cardiovasc Pathol. 2010;19:171–82.PubMedCrossRefGoogle Scholar
  28. 28.
    Kim SH, Song JM, Jung IH, et al. Initial echocardiographic characteristics of pericardial effusion determine the pericardial complications. Int J Cardiol. 2009;136:151–5.PubMedCrossRefGoogle Scholar
  29. 29.
    Hernandez CM, Singh P, Hage FG, et al. Live/real time three-dimensional transthoracic echocardiographic assessment of pericardial disease. Echocardiography. 2009;26:1250–63.PubMedCrossRefGoogle Scholar
  30. 30.
    Rajiah P, Kanne JP. Computed tomography of the pericardium and pericardial disease. J Cardiovasc Comput Tomogr. 2010;4:3–18.PubMedCrossRefGoogle Scholar
  31. 31.
    Bogaert J, Francone M. Cardiovascular magnetic resonance in pericardial diseases. J Cardiovasc Magn Reson. 2009;11:11–4.CrossRefGoogle Scholar
  32. 32.
    Napolitano G, Pressacco J, Paquet E. Imaging features of constrictive pericarditis: beyond pericardial thickening. Can Assoc Radiol J. 2009;60:40–6.PubMedCrossRefGoogle Scholar
  33. 33.
    Schwefer M, Aschenbach R, Heidemann J, et al. Constrictive pericarditis, still a diagnostic challenge: comprehensive review of clinical management. Eur J Cardiothorac Surg. 2009;36:502–10.PubMedCrossRefGoogle Scholar
  34. 34.
    • Yared K, Baggish AL, Picard MH, et al. Multimodality imaging of pericardial diseases. JACC Cardiovasc Imaging. 2010;3:650–60. This is an updated review on multimodality imaging of pericardial diseases.PubMedCrossRefGoogle Scholar
  35. 35.
    • Verhaert D, Gabriel RS, Johnston D, et al. The role of multimodality imaging in the management of pericardial disease. Circ Cardiovasc Imaging. 2010;3:333–43. This is a contemporary review on integrated imaging for pericardial diseases.PubMedCrossRefGoogle Scholar
  36. 36.
    Azam S, Hoit BD. Treatment of pericardial disease. Cardiovasc Ther. 2010 (Epub ahead of print).Google Scholar
  37. 37.
    • Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases: part I: idiopathic and infectious pericarditis. J Cardiovasc Med (Hagerstown). 2010;11:712–22. This and the reference that immediately follows represent an updated review on the medical therapy for pericardial diseases in two parts.Google Scholar
  38. 38.
    Imazio M, Brucato A, Mayosi BM, et al. Medical therapy of pericardial diseases: part II: noninfectious pericarditis, pericardial effusion and constrictive pericarditis. J Cardiovasc Med (Hagerstown). 2010;11:785–94.CrossRefGoogle Scholar
  39. 39.
    Cornily JC, Pennec PY, Castellant P, et al. Cardiac tamponade in medical patients: a 10-year follow-up survey. Cardiology. 2008;111:197–201.PubMedCrossRefGoogle Scholar
  40. 40.
    • Imazio M, Brucato A, Cumetti D, et al. Corticosteroids for recurrent pericarditis: high versus low doses: a nonrandomized observation. Circulation. 2008;118:667–71. This was the first comparative study on the use of high versus low doses of corticosteroids for recurrent pericarditis.PubMedCrossRefGoogle Scholar
  41. 41.
    Farand P, Bonenfant F, Belley-Côté EP, Tzouannis N. Acute and recurring pericarditis: more colchicine, less corticosteroids. World J Cardiol. 2010;2:403–7.PubMedCrossRefGoogle Scholar
  42. 42.
    • Lotrionte M, Biondi-Zoccai G, Imazio M, et al. International collaborative systematic review of controlled clinical trials on pharmacologic treatments for acute pericarditis and its recurrences. Am Heart J. 2010;160:662–70. This is the first meta-analysis on medical therapies for acute and recurrent pericarditis.PubMedCrossRefGoogle Scholar
  43. 43.
    Frasiolas JA, Cahoon WD. Intrapericardial triamcinolone administration for autoreactive pericarditis. Ann Pharmacother. 2010;44:1641–6.PubMedCrossRefGoogle Scholar
  44. 44.
    • Imazio M, Brucato A, Trinchero R, et al. Colchicine for pericarditis: hype or hope? Eur Heart J. 2009;30:532–9. This is an updated and comprehensive review on the use of colchicine in the medical treatment of pericarditis.PubMedCrossRefGoogle Scholar
  45. 45.
    Imazio M, Trinchero R, Adler Y. Colchicine for the treatment of pericarditis. Future Cardiol. 2008;4:599–607.PubMedCrossRefGoogle Scholar
  46. 46.
    Terkeltaub RA. Colchicine update: 2008. Semin Arthritis Rheum. 2009;38:411–9.PubMedCrossRefGoogle Scholar
  47. 47.
    Cocco G, Chu DC, Pandolfi S. Colchicine in clinical medicine. A guide for internists. Eur J Intern Med. 2010;21:503–8.PubMedCrossRefGoogle Scholar
  48. 48.
    • Lestuzzi C, Bearz A, Lafaras C, et al. Neoplastic pericardial disease in lung cancer: impact on outcomes of different treatment strategies. A multicenter study. Lung Cancer. 2010;(Epub ahead of print). This was the first comparative study on different treatment strategies for neoplastic pericarditis in lung cancer patients.Google Scholar
  49. 49.
    • Imazio M, Trinchero R. Myopericarditis: etiology, management, and prognosis. Int J Cardiol. 2008;127:17–26. This is an updated contemporary review on myopericarditis with a focus on practical management.PubMedCrossRefGoogle Scholar
  50. 50.
    Machado S, Roubille F, Gahide G, et al. Can troponin elevation predict worse prognosis in patients with acute pericarditis? Ann Cardiol Angeiol (Paris). 2010;59:1–7.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  1. 1.Cardiology Department Maria Vittoria HospitalTorinoItaly

Personalised recommendations